Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jianheng Peng
Observed names:
J M Peng,
J Peng
Institution:
The Affiliated Yongchuan Hospital of Chongqing Medical University
Observed institutions:
Baylor College of Medicine,
The Affiliated Yongchuan Hospital of Chongqing Medical University,
First Affiliated Hospital of Nanchang University,
Sichuan University of Science and Engineering
ORCID:
0009-0007-5861-6632
Observed ORCID:
0009-0007-5861-6632
OpenAlex ID:
A5001363598
Myeloperoxidase (MPO) and Interleukin-17 (IL-17) Plasma Levels are Increased in Patients with Acute Coronary Syndromes
2009
·
J Liang
, Z Zheng
, et al.
·
Journal of International Medical Research
·
28
Determination of malathion content in sorghum grains using hyperspectral imaging technology combined with stacked machine learning models
2024
·
Jianheng Peng
, Jiahong Zhang
, et al.
·
Journal of Food Composition and Analysis
·
25
CLNet: A fusion network capturing spectral features and wavelength relationships for predicting sorghum protein and moisture content
2025
·
Xinjun Hu
, Mingkui Dai
, et al.
·
Journal of Food Composition and Analysis
·
19
Hyperspectral imaging combined with convolutional neural network for Pu'er ripe tea origin recognition
2024
·
Manjiao Chen
, Wang Guo
, et al.
·
Journal of Food Composition and Analysis
·
19
Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
·
Cancer Research Communications
·
9
PDF
Classification of Pesticide Residues in Sorghum Based on Hyperspectral and Gradient Boosting Decision Trees
2024
·
Xinjun Hu
, Jiahong Zhang
, et al.
·
Journal of Food Safety
·
8
Rapid sorghum variety identification by hyperspectral imaging combined with super-depth-of-field microscopy
2024
·
Xinjun Hu
, Mingkui Dai
, et al.
·
Journal of Food Composition and Analysis
·
4
Comprehensive characterization of SLC41A3 identifies it as an immune-related prognostic biomarker and therapeutic target in hepatocellular carcinoma
2026
·
Biyan Gong
, Dunfu Cao
, et al.
·
Frontiers in Immunology
·
1
Integrated Pan-Cancer Analysis and Functional Characterization Identify SHC2 as a Potential Prognostic Biomarker in Colon Adenocarcinoma
2026
·
Huimin Zhang
, Ran Tian
, et al.
·
Anti-Cancer Agents in Medicinal Chemistry
PDF
Identification and Classification of Lotus Root Powder Using Hyperspectral Imaging Combined with Machine Learning
2024
·
Jianheng Peng
, Xinjun Hu
, et al.
·
International Conference on Artificial Intelligence and Big Data (ICAIBD)
Research on Pancreas Segmentation Method Based on Cascade U-Shaped Network
2024
·
Songcai Yan
, Xinjun Hu
, et al.
·
International Conference on Artificial Intelligence and Big Data (ICAIBD)
Determination of Pesticide Content in Sorghum Grains Using Hyperspectral Imaging Technology Combined with Stacked Machine Learning Models
2024
·
Jiahong Zhang
, Jianheng Peng
, et al.
·
SSRN Electronic Journal
FIGURE 6 from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
Table S1 from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
FIGURE 4 from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
FIGURE 1 from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
FIGURE 2 from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
Figure S1 from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
PDF
Figure S4 from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
Figure S5 from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
FIGURE 1 from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
Table S3 from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
FIGURE 3 from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
Table S2 from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
Figure S1 from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment
2023
·
Beom-Jun Kim
, Ze-Yi Zheng
, et al.
Show more works
View as search
Works count:
59
Citation count:
113
H-index:
6
I10-index:
4
Year
Topic
Type